The 2024 presidential election has ushered in Donald Trump’s return to the White House. With it, questions arise about the future of health care policy and implications for the ambulatory surgery center (ASC) industry. “President Trump was president for four years, so it’s not like we’re walking into this completely blind,” J. Blake Peart, managing director at health care advisory firm Vertess, told ASC News. The Affordable Care Act (ACA) remains a critical issue, Peart said. During his … [Read more...]
Tenet CEO Anticipates More Favorable Regulatory Landscape for ASC Consolidation
With the potential for regulatory changes on the horizon, particularly regarding antitrust policies, Tenet Healthcare Corporation (NYSE: THC) CEO Saum Sutaria said that a more favorable environment for mergers and acquisitions in the coming years could support further healthcare consolidation. Such a change would support ambulatory surgery center (ASC) dealmaking, although Sutaria noted that ASC merger and acquisition activity is unlikely to trigger antitrust concerns under any circumstances … [Read more...]
Tenet Healthcare CEO: ASC Business Experiencing ‘Incredibly Busy Year’
Tenet Healthcare Corporation (NYSE: THC) is experiencing an “incredibly busy year” when it comes to United Surgical Partners International (USPI), its large ambulatory surgery center (ASC) business. In part, all of the action is driven by an increase in ASC higher-acuity caseload, with total joint replacements in Tenet’s ASCs up 23% year over year, with ongoing growth in urology and gastrointestinal (GI) procedures as well. Overall same-facility surgery volumes for Tenet’s ambulatory arm were … [Read more...]